The impact of re-induction prior to salvage autologous stem cell transplantation in multiple myeloma

Analysis of Clinical Factors and Outcomes Associated with Nonuse of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant-Eligible Patients with Multiple Myeloma

(2018) Ankit Kansagra et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement

(2018) Wilson I. Gonsalves et al.   BONE MARROW TRANSPLANTATION

Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignancies

(2018) Praful Ravi et al.   Blood Cancer Journal

Pros and cons of frontline autologous transplant in multiple myeloma: the debate over timing

(2018) Shaji K. Kumar et al.   BLOOD

Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapse

(2018) Surbhi Sidana et al.   LEUKEMIA

Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma

(2018) M. Hasib Sidiqi et al.   Blood Cancer Journal

Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials

(2017) Juan-Jose Lahuerta et al.   JOURNAL OF CLINICAL ONCOLOGY

Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma

(2017) Michel Attal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Multiple myeloma

(2017) Shaji K. Kumar et al.   Nature Reviews Disease Primers

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

(2016) Shaji Kumar et al.   LANCET ONCOLOGY

Cost-Effectiveness of Autologous Hematopoietic Stem Cell Transplantation for Elderly Patients with Multiple Myeloma using the Surveillance, Epidemiology, and End Results–Medicare Database

(2015) Gunjan L. Shah et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Impact of Pretransplant Therapy and Depth of Disease Response before Autologous Transplantation for Multiple Myeloma

(2015) Ravi Vij et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation

(2015) Nina Shah et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Guidelines for determination of the number of prior lines of therapy in multiple myeloma

(2015) S. V. Rajkumar et al.   BLOOD

The future of autologous stem cell transplantation in myeloma

(2014) F. van Rhee et al.   BLOOD

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

(2014) S Vincent Rajkumar et al.   LANCET ONCOLOGY

Early or delayed transplantation for multiple myeloma in the era of novel therapy: does one size fit all?

(2014) P. G. Richardson et al.   Hematology-American Society of Hematology Education Program

Autologous retransplantation for patients with recurrent multiple myeloma

(2013) Leopold Sellner et al.   CANCER

Importance of Achieving Stringent Complete Response After Autologous Stem-Cell Transplantation in Multiple Myeloma

(2013) Prashant Kapoor et al.   JOURNAL OF CLINICAL ONCOLOGY

Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study

(2013) Andy C. Rawstron et al.   JOURNAL OF CLINICAL ONCOLOGY

A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control

(2013) B Paiva et al.   LEUKEMIA

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

(2013) S K Kumar et al.   LEUKEMIA

Second auto-SCT for treatment of relapsed multiple myeloma

(2012) W I Gonsalves et al.   BONE MARROW TRANSPLANTATION

Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics

(2012) Y Kanda   BONE MARROW TRANSPLANTATION

Early versus delayed autologous stem cell transplant in patients receiving novel therapies for multiple myeloma

(2012) Neil C. Dunavin et al.   LEUKEMIA & LYMPHOMA

Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

(2011) S. V. Rajkumar et al.   BLOOD

Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myeloma

(2011) Shaji K. Kumar et al.   CANCER

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

(2008) A Dispenzieri et al.   LEUKEMIA